. One patient in the cardioplegia group had a perioperative infarct on electrocardiographic and biochemical grounds. This patient developed a new q wave on electrocardiography accompanied by large increases in cTnT (> 10 jug/l) and creatine kinase-MB isoenzyme (>300 jug/l). This patient's data have not been included in the diagram comparing cTnT concentrations between the groups.
The figure shows that there was a highly significant (p < 0-001) increase in cTnT concentration one hour after the end of cardiopulmonary bypass and cTnT continued to increase to peak values at the sixth hour after operation. The peak median (75% interquartile range) concentrations of cTnT were similar in both groups (1-8 (1 0-3 6) ug/l for cardioplegia v 1-9 (1-0-3 5) ,ug/l for intermittent ischaemic arrest). At 72 hours cTnT concen-0) I-O-trations were still significantly raised and similar in both groups (0-6 (0-4-1X3) jug/l for cardioplegia v 0-65 (0 5-1 2) ug/l for intermittent ischaemic arrest). There was no significant difference in cTnT concentrations between the groups at any time.
With the exception of the single patient with a perioperative infarct serial electrocardiograms after the operation only showed occasional minor ST-T wave changes. The patient with the perioperative infarct remained clinically well and was discharged on the eighth postoperative day. All other patients had an uneventful recovery and were discharged home on the seventh or eighth postoperative day.
Discussion
Cardiac arrest with antegrade cold crystalloid cardioplegia is currently the most widely used technique for myocardial protection during coronary artery surgery. 1 2 Attempts to improve both the composition of cardioplegia and its distribution through diseased coronary vessels has led to increasingly elaborate modifications including cold blood cardioplegia given antegradely through the aortic root'6 or retrogradely through the coronary sinus,'7 substrate enrichment with glutamate,'8 a warm infusion of cardioplegia "hot shot" before removal of the cross clamp,'9 and most recently the use of warm blood cardioplegia.20 21 There is, however, little clinical evidence to justify these increasingly complex techniques except in repeat coronary surgery (where retrograde cardioplegia may reduce the risk of embolisation from diseased grafts). The supposed superiority of the newer techniques over antegrade cold crystalloid cardioplegia has been shown in laboratory experiments and in retrospective and non-randomised studies. Such studies are notoriously unsound. Since 1980 only two clinical trials have compared cardioplegia and intermittent ischaemic arrest in a prospective, randomised, manner. Pepper and colleagues randomised 50 patients to cardioplegia or intermittent ischaemic arrest at 32°C and found no significant difference in myocardial protection but extrapolated the data to suggest that cardioplegia might confer greater benefit for longer ischaemic periods.2 Flameng and colleagues randomised 72 patients to intermittent ischaemic arrest at 250C, intermittent ischaemic arrest at 32°C, or to cardioplegia. The intermittent ischaemic arrest groups showed fewer rhythm disturbances whereas the cardioplegia group showed better early functional recovery (probably by improved preservation of high energy phosphates).' There was, however, no significant difference in the release of creatine kinase MB isoenzyme between the groups. 3 Serial measurements of cTnT in our trial show that cardioplegia and intermittent ischaemic arrest provide a similar degree of myocardial protection. The cTnT concentrations are similar to those we found in another series of patients undergoing coronary surgery with intermittent ischaemic arrest,'4 and the peak concentrations of <2-5 ,ug/l in both groups probably rule out any noteable myocardial damage."
Two notes of caution are warranted. Firstly this trial contains only a few patients and raises the possibility of a type 2 statistical error. We think this is unlikely in view of the sensitivity and specificity of cTnT and the qualitative and quantitative similarity of the cTnT response in both groups. Indeed, based on our results, to detect a 20% reduction in peak cTnT with cardioplegia with a power of 800/o at the 5% level of significance would require randomisation of 240 patients (Dr A Bowman, Department of Statistics, Glasgow University, personal communication).
Secondly, our trial only examined myocardial protection in patients with relatively short cross clamp times and at least moderately good left ventricular function. It is not clear from our study how intermittent ischaemic arrest would compare with cardioplegia in patients with longer cross clamp times or severely impaired left ventricular function.
Our study implies that intermittent ischaemic arrest provides a similar level of myocardial protection to cardioplegia when ischaemic times are short and is consistent with the clinical results reported by advocates of non-cardioplegic myocardial revascularisation.?8 In a consecutive series of 3000 patients undergoing primary coronary revascularisation with intermittent ischaemic arrest the mortality for elective operation was 0 5% with an overall mortality of 1-47% (including 30% of patients who were aged >70, 10% with ejection fractions <30%, and 31% with unstable angina). Although our study excluded patients with severe left ventricular impairment Boncheck and colleagues have emphasised the advantages of intermittent ischaemic arrest in such patients; in their consecutive series of 290 patients with an ejection fraction of <30% the mortality was 6.2%.8
There are sound physiological reasons why intermittent ischaemic arrest might provide effective myocardial protection. Murray and colleagues described the phenomenon of ischaemic "preconditioning" when they showed that a brief period of ischaemia followed by a brief period of reperfusion made the heart more resistant to a subsequent lengthier period of ischaemia. 22 Preconditioning has now been shown in animal species and although the exact mechanism is uncertain23 there is increasing evidence that it is an adenosine mediated effect through Al receptors.24 Preconditioning of myocardium during coronary artery surgery with intermittent ischaemic arrest has recently been shown to result in better preservation of ATP during subsequent periods of ischaemia. 25 Our technique of intermittent ischaemic arrest is simpler than that usually described."-378 It relies on venous drainage through a two stage atrial cannula and aortic return without venting of the left ventricle (thereby minimising the chance of air embolism). Furthermore the systemic temperature is merely allowed to drift to 340C without active cooling or topical hypothermia. There are, however, potential limitations of intermittent ischaemic arrest: it is contraindicated in patients with extensive calcific degeneration of the aorta where repeat clamping might precipitate dissection or embolisation of particulate debris. In patients undergoing repeat coronary revascularisation where there are heavily diseased but patent grafts, retrograde cardioplegia, at least theoretically, reduces the risk of embolisation. Finally, because of a greater pressure for relatively speedy completion of distal anastomoses with intermittent ischaemic arrest this technique is not ideal for the training of junior cardiac surgeons.
In conclusion this study shows that intermittent ischaemic arrest provides equivalent myocardial protection to cold crystalloid cardioplegia in patients with moderate left ventricular function undergoing first time coronary artery surgery with short ischaemic times. Furthermore in such patients systemic hypothermia to less than 34°C and the use of left ventricular venting seem unnecessary adjuncts to intermittent itchaemic arrest.
